A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model

Anti-PD-1/PD-L1 immunotherapy has limited efficacy in hepatocellular carcinoma (HCC) and does not benefit all patients. A FAK inhibitor (VS-4718) has been reported to improve the microenvironment in some tumors. This study aimed to investigate the effect of the combination of the FAK inhibitor VS471...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuhua Wei (Author), Yufeng Wang (Author), Nanbin Liu (Author), Ran Qi (Author), Yan Xu (Author), Kun Li (Author), Yu Feng (Author), Baomin Shi (Author)
Format: Book
Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available